On September 8, 2022 Helsinn Group ("Helsinn"), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets, in conjunction with Conquer Cancer, the ASCO (Free ASCO Whitepaper) Foundation, reported Dr. Rushil V. Patel as the 2022 recipient of the Conquer Cancer – Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care (Press release, Helsinn, SEP 8, 2022, View Source [SID1234619491]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Helsinn established the Anna Braglia Endowed Young Investigator Award (YIA) through an endowment to Conquer Cancer. The Young Investigator Award (YIA) funds physicians, determined by Conquer Cancer, who are in the final years of their training to aid their transition from a fellowship program to a faculty appointment. The YIA is a one-year $50,000 grant that aims to promote quality research in clinical oncology.
Dr. Patel will study the cultural values and related preferences regarding palliative care of the Hindu community in the Charlotte, North Carolina metropolitan area of the United States, to identify common themes. Once these themes have been identified, Dr. Patel and his team will prepare a survey to be shared with Hindu patients and caregivers from other US cities, to further understand palliative care preferences in Hindu communities throughout the US.
Dr. Patel is a third-year hematology/oncology fellow at the Atrium Health Levine Cancer Institute in Charlotte, North Carolina. He received his medical degree from the University of North Carolina at Chapel Hill before completing internal medicine residency training at Cone Health in Greensboro, North Carolina. Following his residency, Dr. Patel completed a hospice and palliative medicine fellowship at Memorial Sloan Kettering Cancer Center where he became interested in how religion and spirituality influenced palliative care for cancer patients. After this, Dr. Patel was then selected as the Frances Young Tang Research Fellow in Palliative Medicine and completed a study on the spiritual and palliative care needs of hospitalized cancer patients who identified with the Dharmic religions. Dr. Patel has also completed the University of Michigan’s one-year Integrative Oncology Scholars Program.
The Conquer Cancer – Anna Braglia Endowed YIA in Cancer Supportive Care was established in 2016 to honor the life of Anna Braglia, the wife of Helsinn Group Founder and Chairman, Gabriele Braglia, and mother of Helsinn Group Executive Chairman, Riccardo Braglia, following her passing in 2015.
Giorgio Calderari, Helsinn Group CEO, commented: "Dr. Patel’s research into how different cultural minorities view palliative care is a cause that resonates with Helsinn and we are impressed by his passion to make a difference within these communities. At Helsinn, we strive to develop treatments and provide the best support for cancer patients and their families and are pleased to be able to support important research projects like the one Dr. Patel is leading."
Dr. Rushil V. Patel, commented: "Receiving the Young Investigator Award for a subject that is so close to my heart is a true honor. Being recognized by both Conquer Cancer and Helsinn is a great validation of the work we are doing, and I am hopeful that through this project we will be able to bridge the gap in palliative care across different communities."